27th May 2025 14:42
Verici Dx plc
("Verici Dx" or the "Company")
Result of General Meeting
Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that at the General Meeting ("GM") held earlier today, all resolutions, as set out in the GM notice published on 9 May 2025, were duly passed on a poll. Resolution 1 was passed as an ordinary resolution and resolution 2 was passed as a special resolution.
The voting results of the GM were as follows:
| In Favour | Against | Withheld | ||
Resolution | Votes | % | Votes | % | Votes |
1 | 112,453,134 | 99.96 | 47,616 | 0.04 | 23,820 |
2 | 112,380,881 | 99.89 | 119,738 | 0.11 | 23,951 |
Verici Dx plc
| www.vericidx.com | |
Sara Barrington, CEO | Via Walbrook PR | |
| ||
Singer Capital Markets (Nominated Adviser and Broker) | Tel: +44 (0)20 7496 3000 | |
Phil Davies / Sam Butcher | ||
| ||
Walbrook PR (Media & Investor Relations) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Alice Woodings / Paul McManus | Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 | |
| ||
Related Shares:
Verici Dx